Home›People›C. Richard Piazza
CP

C. Richard Piazza

Director at Novascan.

DirectorPublic company
Updated Nov 9, 2026·Latest SEC filing Aug 18, 2026·Suggest an edit

About C. Richard Piazza

C. Richard Piazza is a director at Novascan.

C. Richard Piazza reports to the SEC as a director or officer of 2 public companies: Telix Qsam (QSAM) and Chemokine Therapeutics (CHKT).

C. Richard Piazza first appears on SEC filings in 2006.

Experience

This experience comes from C. Richard Piazza's profile and from SEC filings. For roles taken from filings, the years are when the filings name C. Richard Piazza in the role, so the role may have started earlier or lasted longer.

Novascan Inc. Current
Chairman Of The Board
2017 – Present · Milwaukee, WI
NovaScan develops cancer detection devices to help surgeons assess tissue during surgery.
IGL Pharma, Inc (foremrly CycloSam Therapeutics) Current
President & CEO
2017 – Present
Leaders in Medical Devices & Biotechnology in Houston Current
Founder | CEO Medical Devices Biotechnology
2015 – Present
BioHouston Current
Advisory Board | Biotechnology | Medical Devices
2005 – Present
Telix Qsam Inc.
Executive Chairman
2022 – 2024 · Public company (QSAM)
QSAM Biosciences, Inc.
Executive Chairman & Co-Founder
2020 – 2024
AAVP Biosystems
President & CEO | Biotechnology | Cancer Therapy | Funding | Capitalization
2013 – 2014
La Jolla Capital Partners, LLC
CEO | Medical Devices | Diagnostics | Team Building | Brand Development
2006 – 2013
Chemokine Therapeutics Corp.
Chairman | President & CEO | Biotechnology
2000 – 2009 · Public company (CHKT)
VitaGen
President & CEO | Biotechnology | Medical Devices | Capital Acquisition | Venture Funding
2002 – 2005
Vital Therapies, Inc. (formerly VitaGen)
President & CEO | Biotechnology | Medical Devices | Capital Acquisition | Venture Funding
1994 – 2005
MAXIA Pharmaceuticals
President & CEO | Biotechnology | Capital Formation | Divestiture
2001 – 2002
Marquest Medical Products
President & CEO | Medical Devices | Turnarounds | Public Company
1992 – 1993
SoloPak Pharmaceuticals
President & CEO | Pharmaceuticals | International
1988 – 1992

Key Colleagues at Startups

The people C. Richard Piazza works with at each company, as listed on that company's latest Form D.

Novascan Inc. · Form D/A, Aug 18, 2026
RZ
AM
Amit Mehta
Executive officer and director
CD
Craig Davis
CEO and director

Sources

  1. SECNovascan Inc. Form D/A, filed Aug 18, 2026
  2. SECForms 3, 4 and 5 filed by C. Richard Piazza (SEC filer 1313183)